Vancomycin: New Perspectives on an Old Drug

Journal of Infusion Nursing

Volumn 26, Issue 5, 2003, Pages 278-284

  Hadaway, Lynn ^a   Chamallas, Stanley N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANAPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG EXTRAVASATION; DRUG HYPERSENSITIVITY; DRUG INCOMPATIBILITY; DRUG MONITORING; DRUG STABILITY; FLOW RATE; GAIT DISORDER; HEADACHE; HUMAN; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NURSE; OSMOLALITY; OTOTOXICITY; PATIENT MONITORING; PH; PHLEBITIS; PRIORITY JOURNAL; REVIEW; VASCULAR ACCESS; VERTIGO; VOMITING; CHEMISTRY; CONTRAST MEDIUM EXTRAVASATION; DRUG FORMULATION; INTRAVENOUS DRUG ADMINISTRATION; NURSING; OSMOLARITY;

ANTI-BACTERIAL AGENTS; DRUG COMPOUNDING; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; OSMOLAR CONCENTRATION; VANCOMYCIN;

EID: 0141975408     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200309000-00003     Document Type: Review

References (29)

1. Kastango ES, Hadaway L. New perspectives on vancomycin use in home care: part 1. Int J Pharmaceutical Compounding. 2001;5(6):465-469.
2. Tenover F, Biddle J, Lancaster M. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureas. Emerg Infect Dis. 2001;7(2):327-332.
3. MMWR. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Centers for Disease Control: Morbidity and Mortality Weekly Report. 5-2-01. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00039349.htm. Accessed May 28, 2002.
4. MMWR. Preventing emerging infectious diseases: A strategy for the 21st century overview of the updated DCD plan. Centers for Disease Control Morbitity, and Mortality Weekly Report. 5-02-01. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ 00054779.htm. Accessed May 28, 2002.
5. MMWR. Staphylococcus aureus resistant to vancomycin-United States, 2002. Centers for Disease Control. Available at: http://cdc.gov/mmwr/preview/mmwrhtml/mm5126a1.htm. Accessed July 3, 2002.
6. Corrigan A. History of intravenous therapy. In: Hankins J, Lonsway R, Hedrick C, Perdue M, eds. Infusion Therapy in Clinical Practice. 2nd ed. Philadelphia: WB Saunders Company; 2001:1-5.
7. Ryder MA. Peripherally inserted central venous catheters. Nurs Clin North Am. 1993;28(4):937-971.
8. Kastango E, Hadaway L. New perspectives on vancomycin use in home care, part 2: Delivery systems. Int J Pharmaceutical Compounding. 2002;6(1):55-57.
9. Stranz M. Adjusting pH and osmolarity levels to fit standards and practices. J Vasc Access Devices. 2002;7(3):12-18.
10. Wermeling D, Rapp R, Deluca P, Piecoro J. Osmolality of small-volume intravenous admixtures. Am J Hospital Pharmacy. 1985;42:1739-1744.
11. Bing C. Extended Stability for Parenteral Drugs. Bethesda, Md: American Society of Health-System Pharmacists; 2001.
12. Metheny N. Fluid & Electrolyte Balance: Nursing Considerations. 4th ed. Philadelphia: Lippincott; 2000.
13. INS. Infusion nursing standards of practice. J Intraven Nurs. 2000;23(6S).
14. Trissel LA. Handbook on Injectable Drugs. 9th ed. Bethesda, Md: American Society of Health-System Pharmacists; 1996.
15. Weinstein S. Plumer's Principles and Practice of Intravenous Therapy. 7th ed. Philadelphia: Lippincott; 2001.
16. Renz C, Thurn J, Finn H, Lynch J, Moss J. Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med. 1999;27:1732-1737.
17. Stier G, McGory R, Spotnitz W, Schwenzer K. Hemodynamic effects of rapid vancomycin infusion in critically ill patients. Anesth Analg. 1990;71(4):394-399.
18. Kaenel Wv, Bloomfield E, Amaranath L, Wilde A. Vancomycin does not enhance hypotension under anesthesia. Anesth Analg. 1993;76(4):809-811.
19. James J, Palmer S, Levine D, Rybak M. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother. 1996;40(3):696-700.
20. Bernard E, Perbost I, Carles M, et al. Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic gram-positive bone and joint infections. Clin Microbiol Infect. 1997;3(4):440-446.
21. Klepser M, Patel K, Nicolau D, Quintiliani R, Nightingale C. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy. 1998;18(5):1069-1074.
22. Filippo AD, Gaudio AD, Novelli A, et al. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy. 1998;44(1):63-68.
23. Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study. Antimicrob Agents Chemother. 2002;45(9):2460-2467.
24. Cohen E, Dadashev A, Drucker M, Samra Z, Rubinstein E, Garty M. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. J Antimicrob Chemother. 2002;49(1):155-160.
25. Perucca R. Infusion therapy equipment: Types of infusion therapy equipment. In: Hankins J, Lonsway R, Hedrick C, Perdue M, eds. Infusion Therapy in Clinical Practice. 2nd ed. Philadelphia: WE Saunders Company; 2001.
26. Closson T, Holmes H, McCoy L. Using new technology to reduce antibiotic therapy costs: A case study. Infusion. Jan-Feb 2002:18-25.
27. Tam V, Moore G, Triller D, Briceland L. Vancomycin peak serum concentration monitoring: Implications for home care. J Intravenous Nursing. 1999;22(6):336-342.
28. McCance KL, Huether SE, eds. Pathophysiology: The Biological Basis for Disease in Adults and Children. 3rd ed. St. Louis: Mosby; 1998.
29. Renz C, Laroche D, Thurn J, et al. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology. 1998;89:620-625.